A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Conclusion: Rasagiline is an investigational selective and irreversible inhibitor of MAO-B that has demonstrated efficacy and safety for the treatment of PD. Whether rasagiline is associated with ...

Monoamine oxidase inhibitors (MAOIs) are a group of drugs that treat conditions like depression and Parkinson's disease, ...

Serotonin-norepinephrine reuptake inhibitors (SNRIs ... For instance, taking SNRIs with MAOIs increases the risk of serotonin syndrome. Therefore, you cannot start MAOIs within seven days of ...